UNCOOKED ALERT: Cytokinetics Inc said to ... - Part 4
Speculation is mounting a "third bidder" is rumoured to be circling Cytokinetics, the US-listed biopharmaceutical company, amid rumours several investment banks have secured formal mandates for advanced deal negotiations.
This is paywall protected Betaville Intelligence content. You need to purchase a subscription to access this content. Or get in touch with subscription sales at [email protected] to find out about the different subscription packages on offer.